Real-world study of intranasal ketamine for use in patients with refractory chronic migraine

Hsiangkuo Yuan(Thomas Jefferson University), Michael J. Marmura(Thomas Jefferson University), Jade Park(Rush University), Eugene R. Viscusi(Thomas Jefferson University), Clinton G. Lauritsen(Thomas Jefferson University), Aniket Natekar(OhioHealth)
medRxiv
November 22, 2022
10.1101/2022.11.20.22282558
Cited by 1

Related Papers

Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
|Journal of Pain|2016|3.2k
Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists
|Regional Anesthesia & Pain Medicine|2018|583
Efficacy and Safety of Single and Repeated Administration of 1 Gram Intravenous Acetaminophen Injection (Paracetamol) for Pain Management after Major Orthopedic Surgery
|Anesthesiology|2005|419
Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists
|Regional Anesthesia & Pain Medicine|2018|350
Anaesthetic care of patients undergoing primary hip and knee arthroplasty: consensus recommendations from the International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) based on a systematic review and meta-analysis
|British Journal of Anaesthesia|2019|304